Cargando…

Value of adjuvant chemotherapy in patients with resected stage IB solid predominant and solid non‐predominant lung adenocarcinoma

BACKGROUND: The use of adjuvant chemotherapy (ACT) for stage IB lung adenocarcinoma remains controversial. We examined the benefits of ACT in stage IB patients with tumors composed of solid material. METHODS: The records of 309 patients with stage IB lung adenocarcinoma who had undergone complete re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Shuhui, Teng, Jiajun, Xu, Jianlin, Han, Baohui, Zhong, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360240/ https://www.ncbi.nlm.nih.gov/pubmed/30561142 http://dx.doi.org/10.1111/1759-7714.12942

Ejemplares similares

Efficacy and Benefit of Postoperative Chemotherapy in Micropapillray or Solid Predominant Pattern in Stage IB Lung Adenocarcinoma: A Systematic Review and Meta-Analysis
por: Xu, Congcong, et al.
Publicado: (2021)

Solid predominant histologic subtype and early recurrence predict poor postrecurrence survival in patients with stage I lung adenocarcinoma
por: Luo, Jizhuang, et al.
Publicado: (2016)

Genetic analyses of differences between solid and nonsolid predominant lung adenocarcinomas
por: Luo, Jizhuang, et al.
Publicado: (2018)

Diagnostic value of radial endobronchial ultrasonographic features in predominant solid peripheral pulmonary lesions
por: Zheng, Xiaoxuan, et al.
Publicado: (2020)

Correlation of survival and EGFR mutation with predominant histologic subtype according to the new lung adenocarcinoma classification in stage IB patients
por: Sun, Yan, et al.
Publicado: (2014)

Wedge resection is an acceptable treatment option for radiologically low-grade lung cancer with solid predominance
por: Kamigaichi, Atsushi, et al.
Publicado: (2023)

A Spindle Cell Predominant Pancreatic Solid-pseudopapillary Tumor
por: Go, Jai Hyang
Publicado: (2008)

Prognostic Effects of Predominant Histologic Subtypes in Resected Pulmonary Adenocarcinomas
por: Yaldız, Demet, et al.
Publicado: (2019)

Targeted Sequencing Analysis of Predominant Histological Subtypes in Resected Stage I Invasive Lung Adenocarcinoma
por: Li, Yan, et al.
Publicado: (2021)

Ground Glass Opacity and Adjuvant Chemotherapy in Pathological Stage IB–IIA Lung Adenocarcinoma
por: Zhai, Wenyu, et al.
Publicado: (2022)

Combination of mean CT value and maximum CT value as a novel predictor of lepidic predominant lesions in small lung adenocarcinoma presenting as solid nodules
por: Koezuka, Satoshi, et al.
Publicado: (2022)

Mucinous cystadenoma of the pancreas with predominant stroma creating a solid tumor
por: Ae Lee, Won
Publicado: (2005)

Predominantly Solid Hemangioblastoma Presenting as an Extra-Axial Cerebellopontine Angle Lesion
por: Ahmed, Gasim, et al.
Publicado: (2021)

Segmentectomy versus wedge resection for radiological solid predominant and low metabolic non-small cell lung cancer
por: Kagimoto, Atsushi, et al.
Publicado: (2022)

A novel nomogram for identifying candidates for adjuvant chemotherapy in patients with stage IB gastric adenocarcinoma
por: Xie, Yangyang, et al.
Publicado: (2023)

Multi-omics analysis unravels the underlying mechanisms of poor prognosis and differential therapeutic responses of solid predominant lung adenocarcinoma
por: Li, Feng, et al.
Publicado: (2023)

Minor histological components predict the recurrence of patients with resected stage I acinar- or papillary-predominant lung adenocarcinoma
por: Liu, Wei, et al.
Publicado: (2022)

Adjuvant chemotherapy in patients with recurrence after completely resected stage IB lung adenocarcinoma: Propensity‐matched analysis in a cohort of 147 recurrences
por: Xu, Fei, et al.
Publicado: (2022)

Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma
por: Lee, Po-Hsin, et al.
Publicado: (2023)

Cost-effectiveness analysis of adjuvant therapy with atezolizumab in Chinese patients with stage IB-IIIA resectable NSCLC after adjuvant chemotherapy
por: Chen, Ping, et al.
Publicado: (2022)

Oncologic outcomes of segmentectomy for stage IA radiological solid-predominant lung cancer >2 cm in maximum tumour size
por: Hattori, Aritoshi, et al.
Publicado: (2022)

Adipose Tissue-Derived Biomarkers of Intestinal Barrier Functions for the Characterization of Diarrhoea-Predominant IBS
por: Russo, Francesco, et al.
Publicado: (2018)

Impact on Survival on Interval between Surgery and Adjuvant Chemotherapy in Completely Resected Stage IB-IIIA Lung Cancer
por: Wang, Bing-Yen, et al.
Publicado: (2016)

Glypican-1 is a novel immunohistochemical marker to differentiate poorly differentiated squamous cell carcinoma from solid predominant adenocarcinoma of the lung
por: Kai, Yuichiro, et al.
Publicado: (2021)

The Prognostic Value of Non-Predominant Micropapillary Pattern in a Large Cohort of Resected Invasive Lung Adenocarcinoma Measuring ≤3 cm
por: Zhang, Hua, et al.
Publicado: (2021)

Clinical Features and Outcomes Analysis of Surgical Resected Pulmonary Large-Cell Neuroendocrine Carcinoma With Adjuvant Chemotherapy
por: Shen, Yinchen, et al.
Publicado: (2020)

Prognostic Implication of Predominant Histologic Subtypes of Lymph Node Metastases in Surgically Resected Lung Adenocarcinoma
por: Suda, Kenichi, et al.
Publicado: (2014)

Burden of constipation-predominant irritable bowel syndrome (IBS-C) in France, Italy, and the United Kingdom
por: DiBonaventura, Marco daCosta, et al.
Publicado: (2012)

Noninvasive Biomarkers of Gut Barrier Function in Patients Suffering from Diarrhea Predominant-IBS: An Update
por: Linsalata, Michele, et al.
Publicado: (2020)

Microbial and metabolomic profiles in correlation with depression and anxiety co-morbidities in diarrhoea-predominant IBS patients
por: Liu, Tong, et al.
Publicado: (2020)

Adjuvant Chemotherapy for the Completely Resected Stage IB Nonsmall Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: He, Jiaxi, et al.
Publicado: (2015)

A global assessment of the male predominance in esophageal adenocarcinoma
por: Xie, Shao-Hua, et al.
Publicado: (2016)

Effectiveness of adjuvant systemic chemotherapy for intermediate-risk stage IB cervical cancer
por: Matsuo, Koji, et al.
Publicado: (2017)

Effect of Adjuvant Chemotherapy after Complete Resection for Pathologic Stage IB Lung Adenocarcinoma in High-Risk Patients as Defined by a New Recurrence Risk Scoring Model
por: Jang, Hyo Joon, et al.
Publicado: (2017)

The Predominance of the Clinician
Publicado: (1908)

Adjuvant chemotherapy or immunotherapy for completely resected stage IB non-small cell lung cancer: still a grey zone?
por: Lee, Kuan-Yu, et al.
Publicado: (2023)

Prognostic impact according to the proportion of the lepidic subtype in stage IA acinar‐predominant lung adenocarcinoma
por: Jeon, Hyun Woo, et al.
Publicado: (2021)

Palliative embolisation for intrapulmonary shunting in lepidic predominant adenocarcinoma of the lung
por: Tan, Joanne Yue-Ai, et al.
Publicado: (2015)

Transbronchial lung cryobiopsy for the diagnosis of lepidic-predominant lung adenocarcinoma
por: Pathak, Vikas, et al.
Publicado: (2019)

Deconstructing ADAURA. It is Not Yet Time to Forgo Platinum-based Adjuvant Chemotherapy in Resected Early Stage (IB-IIIA) EGFR-mutant NSCLC
por: Brazel, Danielle, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rm32ab5k659ti491921jl9l8vd